Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT03158454
Active, not recruiting Not applicable

Capsula Closure vs. Non-Capsula Closure: Hip Arthroscopy in Danish Patients With Femoroacetabular Impingement (FAI)

NCT03158454 · tracked via the Priya Life Science Denmark tracker
Sponsor
Aarhus University Hospital
Phase
Not applicable
Started
2017-06-15
Last updated
2025-10-01

Condition(s) studied

Hip Injuries

Investigational drug(s) / intervention(s)

Capsula ClosureNon-Capsula Closure

Capsula Closure: The capsular closure is performed with a minimum of two vicryl # 2 resorbable sutures

Non-Capsula Closure: No capsular closure procedure is performed.

Study summary

The purpose of this study is to investigate whether patients undergoing surgical treatment (hip arthroscopy) of FAI syndrome will positively benefit from capsular closure, in terms of higher scores in validated patient reported outcome measurements, compared to a Group of patients with FAI syndrome where the capsule is left open at the end of the surgical procedure.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Radiological and symptomatic Femoroacetabular Impingement, where surgery is indicated. Preoperatively a minimum of 3 months of relevant physiotherapeutic treatment should have been performed. Exclusion Criteria: * Previous hip surgery in either hip * Malignant disease * Recent hip or pelvic fractures * Arthritic disease * Hip joint dysplasia * Legg-Calvé-Perthes * Slipped Capital Femoris Epiphysis * Recent (within 6 weeks) medical treatment with corticosteroids * Language problems of any kind

Primary outcome measure(s)

  • Change in patient reported outcome scores (Hagos) — From baseline to 2 year after the operation
    Copenhagen Hip and Groin Outcome Score - Questionnaire - Hip-function Score (0-100)

Trial sites (1)

FacilityCityRegionStatus
Division of Sports Trauma, Tage-Hansens Gade 2b Aarhus Denmark

More Aarhus University Hospital trials in Denmark

Body Project SMIL: Prevention of Eating Disorders Among Young Women With Psychiatric Illness With the Body Project Starting soon
Assessment of Residual Congestion in Acute Decompensated Heart Failure Recruiting
Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke Recruiting
Progressive Resistance Training for Adults With External Snapping Hip Recruiting
Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03158454 on ClinicalTrials.gov ↗ ← All trials in Denmark